Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
2011
n/a
LTM Revenue $110M
LTM EBITDA $10.3M
$104M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of August 2025, Trajan Gr Hldgs reported last 12-month revenue of $110M and EBITDA of $10.3M.
In the same period, Trajan Gr Hldgs generated $43.9M in LTM gross profit and $0.7M in net income.
See Trajan Gr Hldgs valuation multiples based on analyst estimatesIn the most recent fiscal year, Trajan Gr Hldgs reported revenue of $109M and EBITDA of $5.3M.
Trajan Gr Hldgs expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Trajan Gr Hldgs valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $110M | XXX | $109M | XXX | XXX | XXX |
Gross Profit | $43.9M | XXX | $41.6M | XXX | XXX | XXX |
Gross Margin | 40% | XXX | 38% | XXX | XXX | XXX |
EBITDA | $10.3M | XXX | $5.3M | XXX | XXX | XXX |
EBITDA Margin | 9% | XXX | 5% | XXX | XXX | XXX |
EBIT | $4.4M | XXX | $2.3M | XXX | XXX | XXX |
EBIT Margin | 4% | XXX | 2% | XXX | XXX | XXX |
Net Profit | $0.7M | XXX | -$2.9M | XXX | XXX | XXX |
Net Margin | 1% | XXX | -3% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $19.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Trajan Gr Hldgs has current market cap of AUD 115M (or $75.2M), and EV of AUD 158M (or $104M).
As of September 19, 2025, Trajan Gr Hldgs's stock price is AUD 1 (or $0).
See Trajan Gr Hldgs trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$104M | $75.2M | XXX | XXX | XXX | XXX | $0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialTrajan Gr Hldgs's trades at 1.0x EV/Revenue multiple, and -24.9x EV/EBITDA.
See valuation multiples for Trajan Gr Hldgs and 15K+ public compsAs of September 19, 2025, Trajan Gr Hldgs has market cap of $75.2M and EV of $104M.
Equity research analysts estimate Trajan Gr Hldgs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Trajan Gr Hldgs has a P/E ratio of 115.3x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $75.2M | XXX | $75.2M | XXX | XXX | XXX |
EV (current) | $104M | XXX | $104M | XXX | XXX | XXX |
EV/Revenue | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
EV/EBITDA | 10.1x | XXX | -24.9x | XXX | XXX | XXX |
EV/EBIT | 23.4x | XXX | 84.1x | XXX | XXX | XXX |
EV/Gross Profit | 2.4x | XXX | n/a | XXX | XXX | XXX |
P/E | 115.3x | XXX | -7.7x | XXX | XXX | XXX |
EV/FCF | 20.8x | XXX | 24.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTrajan Gr Hldgs's last 12 month revenue growth is 6%
Trajan Gr Hldgs's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Trajan Gr Hldgs's rule of 40 is 2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Trajan Gr Hldgs's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Trajan Gr Hldgs and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
EBITDA Margin | 9% | XXX | -4% | XXX | XXX | XXX |
EBITDA Growth | 12% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 2% | XXX | 2% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Trajan Gr Hldgs acquired XXX companies to date.
Last acquisition by Trajan Gr Hldgs was XXXXXXXX, XXXXX XXXXX XXXXXX . Trajan Gr Hldgs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Trajan Gr Hldgs founded? | Trajan Gr Hldgs was founded in 2011. |
Where is Trajan Gr Hldgs headquartered? | Trajan Gr Hldgs is headquartered in Australia. |
Is Trajan Gr Hldgs publicy listed? | Yes, Trajan Gr Hldgs is a public company listed on ASX. |
What is the stock symbol of Trajan Gr Hldgs? | Trajan Gr Hldgs trades under TRJ ticker. |
When did Trajan Gr Hldgs go public? | Trajan Gr Hldgs went public in 2021. |
Who are competitors of Trajan Gr Hldgs? | Similar companies to Trajan Gr Hldgs include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Trajan Gr Hldgs? | Trajan Gr Hldgs's current market cap is $75.2M |
What is the current revenue of Trajan Gr Hldgs? | Trajan Gr Hldgs's last 12 months revenue is $110M. |
What is the current revenue growth of Trajan Gr Hldgs? | Trajan Gr Hldgs revenue growth (NTM/LTM) is 6%. |
What is the current EV/Revenue multiple of Trajan Gr Hldgs? | Current revenue multiple of Trajan Gr Hldgs is 0.9x. |
Is Trajan Gr Hldgs profitable? | Yes, Trajan Gr Hldgs is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Trajan Gr Hldgs? | Trajan Gr Hldgs's last 12 months EBITDA is $10.3M. |
What is Trajan Gr Hldgs's EBITDA margin? | Trajan Gr Hldgs's last 12 months EBITDA margin is 9%. |
What is the current EV/EBITDA multiple of Trajan Gr Hldgs? | Current EBITDA multiple of Trajan Gr Hldgs is 10.1x. |
What is the current FCF of Trajan Gr Hldgs? | Trajan Gr Hldgs's last 12 months FCF is $5.0M. |
What is Trajan Gr Hldgs's FCF margin? | Trajan Gr Hldgs's last 12 months FCF margin is 5%. |
What is the current EV/FCF multiple of Trajan Gr Hldgs? | Current FCF multiple of Trajan Gr Hldgs is 20.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.